Bioxcel Therapeutics Inc Revenue per Employee (BTAI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Bioxcel Therapeutics Inc   (NASDAQ: BTAI)
 

Bioxcel Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 51.67% in the second quarter 2026, year on year to cumulative value of $1 million, Bioxcel Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 25,586, this is below the company average.
Within the Healthcare sector Employees of 534 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 3601, from total ranking in previous quarter at 4156. Bioxcel Therapeutics Inc has 29 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BTAI Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 51.67 % 22.62 % -30.05 % -54.21 % -89.13 %
Sales per Employee (TTM) $ 25,586 23,448 22,138 25,931 29,931
BTAI's Total Ranking # 3601 # 4156 # 3728 # 3737 # 3651
Seq. Revenue Change -11.65 % -19.53 % 161.22 % -18.33 % -28.57 %

BTAI Company Profile >> Back to BTAI Efficiency Comparisons >> Compare BTAI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 191
Healthcare Sector # 535
Overall Market # 3601

Revenue per Employee Statistics
High Average Low
$ 82,862 $ 47,472 $ 22,138
(Jun 30 2024)   (Dec 31 2025)



Financial Statements
Bioxcel Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit BTAI's Income Statement
Bioxcel Therapeutics Inc 's Revenues TTM $ 1 Millions Visit BTAI's aggregate revenue growth
What are BTAI's Sales? Visit BTAI's Sales by Segment




Other Ratios
Bioxcel Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BTAI's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BTAI's Competitors
Revenue per Employee for BTAI's Suppliers
Revenue per Employee for BTAI's Customers

You may also want to know
BTAI's Sales Growth Rates BTAI's Pe Price to earnings ratio BTAI's Receivables Turnover Ratio BTAI's Stock Quote
BTAI's Net Income Growth Rates BTAI's Ps Price to Sales ratio BTAI's Sales per Employee BTAI's Asset Turnover Ratio
BTAI's Net Margin BTAI's Pb Price to Book ratio BTAI's Financial Strength Ratios BTAI's Dividend Payout Ratio
Date modified: 2026-09-03T11:36:13+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Cg Oncology Inc   43,859.15 $ 6.228  Million 142 
Biocorrx Inc   43,701.83 $ 0.787  Million 18 
Vyne Therapeutics Inc   43,000.00 $ 0.430  Million 10 
Femasys Inc   42,581.67 $ 2.299  Million 54 
Upstream Bio Inc   42,106.67 $ 3.158  Million 75 
Sintx Technologies Inc   41,562.50 $ 1.330  Million 32 
Fate Therapeutics Inc   40,316.77 $ 6.491  Million 161 
Ocugen Inc   39,482.76 $ 4.580  Million 116 
Alumis inc   33,026.79 $ 7.398  Million 224 
Volitionrx Limited  32,773.92 $ 2.458  Million 75 
Longeveron Inc   31,236.84 $ 1.187  Million 38 
Entrada Therapeutics Inc   30,828.95 $ 4.686  Million 152 
Dbv Technologies S a   29,517.65 $ 5.018  Million 170 
Addus Homecare Corp  29,128.29 $ 1,475.610  Million 50,659 
Insight Molecular Diagnostics Inc   28,793.10 $ 1.670  Million 58 
Seres Therapeutics Inc   28,530.30 $ 1.883  Million 66 
Scientific Industries Inc   28,357.43 $ 5.728  Million 202 
Prime Medicine Inc   27,897.26 $ 4.073  Million 146 
Nexalin Technology Inc   27,144.38 $ 0.217  Million 8 
Bioxcel Therapeutics Inc   25,586.21 $ 0.742  Million 29 
Bioadaptives Inc   25,561.00 $ 0.026  Million 1 
Ataibeckley Inc   22,143.56 $ 4.473  Million 202 
Envoy Medical Inc   20,700.00 $ 0.207  Million 10 
Northwest Biotherapeutics Inc  20,695.24 $ 2.173  Million 105 
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 
Cardiff Oncology Inc   16,387.10 $ 0.508  Million 31 
Mangoceuticals Inc   14,328.50 $ 0.315  Million 22 
Eyepoint Inc   13,028.04 $ 2.788  Million 214 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.